Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

CV 202-010 (DUSIN). A double-blind, placebo-controlled, randomized, two-stage, parallel-group, adaptive design phase 2a study to evaluate the effects of BMS-813160 (CCR2 and CCR5 receptor antagonist) in subjects with type 2 diabetes and DKD, who have residual macroalbuminuria despite treatment with inhibitor of the RAS system

Projekt: Typer af projekterProjekt

  1. Sleep apnea in type 1 diabetes – SAP1 study

    Projekt: Typer af projekterProjekt

Vis graf over relationer

ID: 44812713